Page last updated: 2024-11-06

n-hydroxyamphetamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-hydroxyamphetamine: metabolite of amphetamine; structure; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65546
SCHEMBL ID125441
MeSH IDM0046863

Synonyms (14)

Synonym
n-hydroxyamphetamine
benzeneethanamine, n-hydroxy-alpha-methyl-
n-(1-phenylpropan-2-yl)hydroxylamine
63-90-1
unii-a2axb2c6cq
a2axb2c6cq ,
AKOS021002860
SCHEMBL125441
DTXSID70870499
n-hydroxy-1-phenylpropan-2-amine
n-hydroxy-.alpha.-methylbenzeneethanamine
benzeneethanamine, n-hydroxy-.alpha.-methyl-
n-(.alpha.-methylphenethyl)hydroxylamine
(+/-)-n-hydroxyamphetamine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (57.14)18.7374
1990's8 (38.10)18.2507
2000's0 (0.00)29.6817
2010's1 (4.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.76%)5.53%
Reviews2 (9.52%)6.00%
Case Studies1 (4.76%)4.05%
Observational0 (0.00%)0.25%
Other17 (80.95%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]